Enfortumab Vedotin + Pembro for Previously Untreated Advanced Urothelial Carcinoma: Results From the EV-302 Trial | VuMedi

Oncology Data Advisor

Enfortumab Vedotin + Pembro for Previously Untreated Advanced Urothelial Carcinoma: Results From the EV-302 Trial

By Oncology Data Advisor FEATURING Thomas Powles

By Oncology Data Advisor FEATURING Thomas Powles

0 views

October 19, 2023

Comments 0

Login to view comments. Click here to Login